Primary tabs

Keytruda Adjuvant Therapy Study Shows Reduced the Risk of Disease Recurrence or Death by More Than 40 Percent Compared to Placebo in Stage III Melanoma
Post date: April 15, 2018 - 1:00pm
The First Successful Transfer of DNA Sequence Over the Ethereum Blockchain
Post date: April 15, 2018 - 12:47pm
NGM Bio Releases Promising Results From Phase 2 Study Of NGM282 In NASH
Post date: April 14, 2018 - 10:09am
Intercept Presents Data form Ph III Substudy That Supports Obeticholic Acid’s Ability to Reverse or Stabilize Fibrosis and Cirrhosis in Primary Biliary Cholangitis (PBC) Patients
Post date: April 13, 2018 - 12:52pm
MediciNova Announces Presentation of Significant Positive Results from Interim Analysis of the Phase 2 Trial of MN-001 (tipelukast) in NASH / NAFLD
Post date: April 13, 2018 - 12:42pm
Gilead Presents Data on Multiple Investigational Regimens for the Treatment of Patients With Nonalcoholic Steatohepatitis (NASH) and Advanced Fibrosis
Post date: April 13, 2018 - 12:10pm
Allergan Announces Launch of the TrueTear Intranasal Neurostimulation Device
Post date: April 13, 2018 - 9:47am
Galapagos Announces ISABELA Ph III Study in Idiopathic Pulmonary Fibrosis
Post date: April 12, 2018 - 8:26pm
Wistar Researchers Find Combination Therapy Effective for NRAS Mutant and Therapy Resistant Melanoma
Post date: April 12, 2018 - 11:56am
Pfizer Commences Ph Ib Trial With Mini-Dystrophin Gene Therapy for the Treatment of Duchenne Muscular Dystrophy
Post date: April 12, 2018 - 9:22am

Pages